Published in J Am Acad Child Adolesc Psychiatry on May 01, 2006
Psychopharmacology: concepts and opinions about the use of stimulant medications. J Child Psychol Psychiatry (2009) 1.91
Comparing the efficacy of medications for ADHD using meta-analysis. MedGenMed (2006) 1.51
Psychostimulants and cognition: a continuum of behavioral and cognitive activation. Pharmacol Rev (2013) 1.13
Modafinil effects in multiple sclerosis patients with fatigue. J Neurol (2009) 1.01
Cognitive enhancers for the treatment of ADHD. Pharmacol Biochem Behav (2011) 0.97
Treatment strategies for co-occurring ADHD and substance use disorders. Am J Addict (2007) 0.87
The ethics of elective psychopharmacology. Int J Neuropsychopharmacol (2011) 0.85
Drug and non-drug treatments of children with ADHD and tic disorders. Eur Child Adolesc Psychiatry (2007) 0.82
The occurrence of adverse drug reactions reported for attention deficit hyperactivity disorder (ADHD) medications in the pediatric population: a qualitative review of empirical studies. Neuropsychiatr Dis Treat (2011) 0.82
Chiropractic care for paediatric and adolescent Attention-Deficit/Hyperactivity Disorder: A systematic review. Chiropr Osteopat (2010) 0.81
Acute modafinil effects on attention and inhibitory control in methamphetamine-dependent humans. J Stud Alcohol Drugs (2011) 0.80
Psychiatric and cognitive phenotype in children and adolescents with myotonic dystrophy. Eur Child Adolesc Psychiatry (2009) 0.80
A review of modafinil film-coated tablets for attention-deficit/hyperactivity disorder in children and adolescents. Neuropsychiatr Dis Treat (2007) 0.79
Efficacy and safety of modafinil film-coated tablets in children and adolescents with or without prior stimulant treatment for attention-deficit/hyperactivity disorder: pooled analysis of 3 randomized, double-blind, placebo-controlled studies. Prim Care Companion J Clin Psychiatry (2006) 0.79
The worldwide prevalence of ADHD: a systematic review and metaregression analysis. Am J Psychiatry (2007) 14.02
The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication. Am J Psychiatry (2006) 11.85
Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs. Nat Genet (2013) 8.02
The MTA at 8 years: prospective follow-up of children treated for combined-type ADHD in a multisite study. J Am Acad Child Adolesc Psychiatry (2009) 6.71
The age-dependent decline of attention deficit hyperactivity disorder: a meta-analysis of follow-up studies. Psychol Med (2006) 5.56
The worldwide prevalence of ADHD: is it an American condition? World Psychiatry (2003) 5.30
The Texas Children's Medication Algorithm Project: revision of the algorithm for pharmacotherapy of attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry (2006) 4.58
Once-daily atomoxetine treatment for children and adolescents with attention deficit hyperactivity disorder: a randomized, placebo-controlled study. Am J Psychiatry (2002) 3.89
Evaluating dopamine reward pathway in ADHD: clinical implications. JAMA (2009) 3.69
3-year follow-up of the NIMH MTA study. J Am Acad Child Adolesc Psychiatry (2007) 3.33
Pharmacologic treatments for pediatric bipolar disorder: a review and meta-analysis. J Am Acad Child Adolesc Psychiatry (2011) 3.26
Meta-analysis of genome-wide association studies of attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry (2010) 3.13
Dopamine in drug abuse and addiction: results of imaging studies and treatment implications. Arch Neurol (2007) 3.11
Variables that affect the clinical use and abuse of methylphenidate in the treatment of ADHD. Am J Psychiatry (2003) 3.10
Effect of stimulants on height and weight: a review of the literature. J Am Acad Child Adolesc Psychiatry (2008) 2.96
Development and natural history of mood disorders. Biol Psychiatry (2002) 2.90
Patterns and predictors of attention-deficit/hyperactivity disorder persistence into adulthood: results from the national comorbidity survey replication. Biol Psychiatry (2005) 2.87
Does stimulant therapy of attention-deficit/hyperactivity disorder beget later substance abuse? A meta-analytic review of the literature. Pediatrics (2003) 2.79
PET study examining pharmacokinetics, detection and likeability, and dopamine transporter receptor occupancy of short- and long-acting oral methylphenidate. Am J Psychiatry (2006) 2.78
Hypericum perforatum (St John's wort) for attention-deficit/hyperactivity disorder in children and adolescents: a randomized controlled trial. JAMA (2008) 2.76
Case-control study of attention-deficit hyperactivity disorder and maternal smoking, alcohol use, and drug use during pregnancy. J Am Acad Child Adolesc Psychiatry (2002) 2.65
Cognitive behavioral therapy for 4- to 7-year-old children with anxiety disorders: a randomized clinical trial. J Consult Clin Psychol (2010) 2.50
Attention-deficit/hyperactivity disorder in adults. JAMA (2004) 2.50
Genome-wide analysis of copy number variants in attention deficit hyperactivity disorder: the role of rare variants and duplications at 15q13.3. Am J Psychiatry (2012) 2.48
Evidence of positive selection acting at the human dopamine receptor D4 gene locus. Proc Natl Acad Sci U S A (2001) 2.48
Cortical thinning of the attention and executive function networks in adults with attention-deficit/hyperactivity disorder. Cereb Cortex (2006) 2.44
Activation of orbital and medial prefrontal cortex by methylphenidate in cocaine-addicted subjects but not in controls: relevance to addiction. J Neurosci (2005) 2.41
Attention-deficit/hyperactivity disorder: diagnosis, lifespan, comorbidities, and neurobiology. J Pediatr Psychol (2007) 2.39
Depressed dopamine activity in caudate and preliminary evidence of limbic involvement in adults with attention-deficit/hyperactivity disorder. Arch Gen Psychiatry (2007) 2.37
Meta-analysis of the efficacy of methylphenidate for treating adult attention-deficit/hyperactivity disorder. J Clin Psychopharmacol (2004) 2.36
A comparison of once-daily extended-release methylphenidate formulations in children with attention-deficit/hyperactivity disorder in the laboratory school (the Comacs Study). Pediatrics (2004) 2.32
Adolescent substance use in the multimodal treatment study of attention-deficit/hyperactivity disorder (ADHD) (MTA) as a function of childhood ADHD, random assignment to childhood treatments, and subsequent medication. J Am Acad Child Adolesc Psychiatry (2013) 2.30
Behavioral inhibition in preschool children at risk is a specific predictor of middle childhood social anxiety: a five-year follow-up. J Dev Behav Pediatr (2007) 2.20
Psychiatric comorbidity and functioning in clinically referred preschool children and school-age youths with ADHD. J Am Acad Child Adolesc Psychiatry (2002) 2.19
Attention deficit/hyperactivity disorder across the lifespan. Annu Rev Med (2002) 2.19
Structural brain magnetic resonance imaging of limbic and thalamic volumes in pediatric bipolar disorder. Am J Psychiatry (2005) 2.18
What is the prevalence of adult ADHD? Results of a population screen of 966 adults. J Atten Disord (2005) 2.16
The clinical use of the MSLT and MWT. Sleep (2005) 2.14
Medication adherence in the MTA: saliva methylphenidate samples versus parent report and mediating effect of concomitant behavioral treatment. J Am Acad Child Adolesc Psychiatry (2009) 2.13
Olanzapine versus placebo in the treatment of adolescents with bipolar mania. Am J Psychiatry (2007) 2.11
Atomoxetine and methylphenidate treatment in children with ADHD: a prospective, randomized, open-label trial. J Am Acad Child Adolesc Psychiatry (2002) 2.10
Expectation enhances the regional brain metabolic and the reinforcing effects of stimulants in cocaine abusers. J Neurosci (2003) 2.08
Cognitive-behavioral therapy for ADHD in medication-treated adults with continued symptoms. Behav Res Ther (2005) 2.08
Parent and teacher SNAP-IV ratings of attention deficit hyperactivity disorder symptoms: psychometric properties and normative ratings from a school district sample. Assessment (2008) 2.05
Developmental origins of health and disease: brief history of the approach and current focus on epigenetic mechanisms. Semin Reprod Med (2009) 2.03
Diagnosing adult attention deficit hyperactivity disorder: are late onset and subthreshold diagnoses valid? Am J Psychiatry (2006) 2.03
Which treatment for whom for ADHD? Moderators of treatment response in the MTA. J Consult Clin Psychol (2003) 2.02
Assessing the molecular genetics of attention networks. BMC Neurosci (2002) 2.02
A large, double-blind, randomized clinical trial of methylphenidate in the treatment of adults with attention-deficit/hyperactivity disorder. Biol Psychiatry (2005) 2.01
Results from 2 proof-of-concept, placebo-controlled studies of atomoxetine in children with attention-deficit/hyperactivity disorder. J Clin Psychiatry (2002) 2.00
Double-blind, placebo-controlled study of the efficacy and safety of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder. J Clin Psychiatry (2008) 1.99
Delinquent behavior and emerging substance use in the MTA at 36 months: prevalence, course, and treatment effects. J Am Acad Child Adolesc Psychiatry (2007) 1.98
A randomized, double-blind, placebo-controlled, parallel-group study of SLI381 (Adderall XR) in children with attention-deficit/hyperactivity disorder. Pediatrics (2002) 1.97
Which SSRI? A meta-analysis of pharmacotherapy trials in pediatric obsessive-compulsive disorder. Am J Psychiatry (2003) 1.91
Validity of pilot Adult ADHD Self- Report Scale (ASRS) to Rate Adult ADHD symptoms. Ann Clin Psychiatry (2006) 1.89
Cognitive control of drug craving inhibits brain reward regions in cocaine abusers. Neuroimage (2009) 1.87
Characteristics of adolescents and young adults with ADHD who divert or misuse their prescribed medications. J Am Acad Child Adolesc Psychiatry (2006) 1.87
Case-control genome-wide association study of attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry (2010) 1.86
Evidence that methylphenidate enhances the saliency of a mathematical task by increasing dopamine in the human brain. Am J Psychiatry (2004) 1.80
Family-based genome-wide association scan of attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry (2010) 1.79
The heavy burden of psychiatric comorbidity in youth with autism spectrum disorders: a large comparative study of a psychiatrically referred population. J Autism Dev Disord (2010) 1.76
Lisdexamfetamine dimesylate and mixed amphetamine salts extended-release in children with ADHD: a double-blind, placebo-controlled, crossover analog classroom study. Biol Psychiatry (2007) 1.75
Subtypes versus severity differences in attention-deficit/hyperactivity disorder in the Northern Finnish Birth Cohort. J Am Acad Child Adolesc Psychiatry (2007) 1.75
Short- and long-term cardiovascular effects of mixed amphetamine salts extended release in children. J Pediatr (2005) 1.74
Reaction time distribution analysis of neuropsychological performance in an ADHD sample. Child Neuropsychol (2006) 1.73
Guanfacine extended release in children and adolescents with attention-deficit/hyperactivity disorder: a placebo-controlled trial. J Am Acad Child Adolesc Psychiatry (2009) 1.73
Dorsolateral prefrontal and anterior cingulate cortex volumetric abnormalities in adults with attention-deficit/hyperactivity disorder identified by magnetic resonance imaging. Biol Psychiatry (2006) 1.70
Stimulants and sudden death: what is a physician to do? Pediatrics (2006) 1.64
Genome-wide copy number variation study associates metabotropic glutamate receptor gene networks with attention deficit hyperactivity disorder. Nat Genet (2011) 1.63
Heterogeneity of irritability in attention-deficit/hyperactivity disorder subjects with and without mood disorders. Biol Psychiatry (2005) 1.62
Comparative efficacy of Adderall and methylphenidate in attention-deficit/hyperactivity disorder: a meta-analysis. J Clin Psychopharmacol (2002) 1.60
Cardiovascular effects of longer-term, high-dose OROS methylphenidate in adolescents with attention deficit hyperactivity disorder. J Pediatr (2009) 1.60
A 30-year prospective follow-up study of hyperactive boys with conduct problems: adult criminality. J Am Acad Child Adolesc Psychiatry (2007) 1.59
Functional magnetic resonance imaging of methylphenidate and placebo in attention-deficit/hyperactivity disorder during the multi-source interference task. Arch Gen Psychiatry (2008) 1.59
A preliminary meta-analysis of the child behavior checklist in pediatric bipolar disorder. Biol Psychiatry (2003) 1.58
Efficacy and safety of modafinil film-coated tablets in children and adolescents with attention-deficit/hyperactivity disorder: results of a randomized, double-blind, placebo-controlled, flexible-dose study. Pediatrics (2005) 1.57
Symptoms versus impairment: the case for respecting DSM-IV's Criterion D. J Atten Disord (2006) 1.55
Association between attention-deficit/hyperactivity disorder and bulimia nervosa: analysis of 4 case-control studies. J Clin Psychiatry (2006) 1.55
Methylphenidate decreased the amount of glucose needed by the brain to perform a cognitive task. PLoS One (2008) 1.54
Cardiorespiratory fitness and obstructive sleep apnea syndrome in morbidly obese patients. Chest (2008) 1.54
Effects of atomoxetine on growth after 2-year treatment among pediatric patients with attention-deficit/hyperactivity disorder. Pediatrics (2005) 1.52
Comparing the efficacy of medications for ADHD using meta-analysis. MedGenMed (2006) 1.51
Attention and executive systems abnormalities in adults with childhood ADHD: A DT-MRI study of connections. Cereb Cortex (2007) 1.51
Long-term effects of extended-release mixed amphetamine salts treatment of attention- deficit/hyperactivity disorder on growth. J Child Adolesc Psychopharmacol (2005) 1.50
Impact of low birth weight on attention-deficit hyperactivity disorder. J Dev Behav Pediatr (2002) 1.49
Meta-analysis of genome-wide linkage scans of attention deficit hyperactivity disorder. Am J Med Genet B Neuropsychiatr Genet (2008) 1.48
Brain dopamine transporter levels in treatment and drug naïve adults with ADHD. Neuroimage (2006) 1.47
Are endophenotypes based on measures of executive functions useful for molecular genetic studies of ADHD? J Child Psychol Psychiatry (2005) 1.47
Psychopathology in the offspring of parents with bipolar disorder: a controlled study. Biol Psychiatry (2005) 1.47
Whole-genome analysis reveals that mutations in inositol polyphosphate phosphatase-like 1 cause opsismodysplasia. Am J Hum Genet (2012) 1.46
Effects of ethnicity on treatment attendance, stimulant response/dose, and 14-month outcome in ADHD. J Consult Clin Psychol (2003) 1.46
How cardinal are cardinal symptoms in pediatric bipolar disorder? An examination of clinical correlates. Biol Psychiatry (2005) 1.46
Observed classroom behavior of children with ADHD: relationship to gender and comorbidity. J Abnorm Child Psychol (2002) 1.45
MRI-based surface-assisted parcellation of human cerebellar cortex: an anatomically specified method with estimate of reliability. Neuroimage (2005) 1.44
Psychiatric comorbidity, family dysfunction, and social impairment in referred youth with oppositional defiant disorder. Am J Psychiatry (2002) 1.43
Self-perceptions of competence in children with ADHD and comparison children. J Consult Clin Psychol (2004) 1.43
A review of the pharmacotherapy of adults with attention-deficit/hyperactivity disorder. J Atten Disord (2002) 1.42
Peer-assessed outcomes in the multimodal treatment study of children with attention deficit hyperactivity disorder. J Clin Child Adolesc Psychol (2005) 1.41